KMDA
Kamada Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$8.85
+2.08%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- $0.14
- Revenue estimate
- $52.8M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- $0.16
- EPS estimate
- $0.11
- Revenue actual
- $54.9M
- Revenue estimate
- $50.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +5.6%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | $0.11 | $0.16 | Beat 42.22% | $54.9M |
| May 13, 2026 | $0.12 | $0.07 | Miss -41.67% | $45.2M |
| Mar 11, 2026 | $0.08 | $0.06 | Miss -22.58% | $45.6M |
| Aug 13, 2025 | $0.09 | $0.13 | Beat 44.44% | $44.8M |
| May 14, 2025 | $0.07 | $0.07 | In line | $44.0M |
| Mar 5, 2025 | $0.05 | $0.07 | Beat 40.00% | $39.0M |
| Aug 14, 2024 | $0.06 | $0.08 | Beat 33.33% | $41.9M |
| Mar 6, 2024 | $0.05 | $0.09 | Beat 80.00% | $38.4M |
| Nov 13, 2023 | $0.03 | $0.06 | Beat 100.00% | $37.9M |
| Aug 16, 2023 | $0.02 | $0.04 | Beat 100.00% | $37.4M |
| May 24, 2023 | -$0.03 | $0.04 | Beat 260.00% | $30.7M |
| Mar 15, 2023 | $0.07 | $0.11 | Beat 57.14% | $45.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026